Recombinant multi-species WFIKKN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WFIKKN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The WFIKKN1 protein contains a WAP domain, follistatin domain, immunoglobulin domain, two tandem Kunitz domains, and an NTR domain. This gene encodes a WFIKKN1-related protein which has the same domain organization as the WFIKKN1 protein. The WAP-type, follistatin type, Kunitz-type, and NTR-type protease inhibitory domains may control the action of multiple types of proteases. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2610304F08Rik,GASP-1,Gasp1,Growth and differentiation factor-associated serum protein 1 (GASP-1,Kazal,Kunitz and NTR domain-containing protein 2,Kunitz and NTR domain-containing-related protein,RGD1305361,WAP,WFDC20B,WFIKKN-related protein,WFIKKN2,WFIKKNRP,Wfikkn2,follistatin,hGASP-1,hGASP-1),immunoglobulin

Target products collectionGo to WFIKKN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0554-Ag-1/ GM-Tg-hg-SE0554-Ag-2 Human WFIKKN2 protein Human
GM-Tg-rg-SE0554-Ag-1/ GM-Tg-rg-SE0554-Ag-2 Rat WFIKKN2 protein Rat
GM-Tg-mg-SE0554-Ag-1/ GM-Tg-mg-SE0554-Ag-2 Mouse WFIKKN2 protein Mouse
GM-Tg-cynog-SE0554-Ag-1/ GM-Tg-cynog-SE0554-Ag-2 Cynomolgus/Rhesus macaque WFIKKN2 monoclonal antigen Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0554-Ag-1/ GM-Tg-felg-SE0554-Ag-2 Feline WFIKKN2 protein Feline
GM-Tg-cang-SE0554-Ag-1/ GM-Tg-cang-SE0554-Ag-2 Canine WFIKKN2 protein Canine
GM-Tg-bovg-SE0554-Ag-1/ GM-Tg-bovg-SE0554-Ag-2 Bovine WFIKKN2 protein Bovine
GM-Tg-equg-SE0554-Ag-1/ GM-Tg-equg-SE0554-Ag-2 Equine WFIKKN2 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0554-Ag-1/ GM-Tg-hg-SE0554-Ag-2; GM-Tg-rg-SE0554-Ag-1/ GM-Tg-rg-SE0554-Ag-2;
GM-Tg-mg-SE0554-Ag-1/ GM-Tg-mg-SE0554-Ag-2; GM-Tg-cynog-SE0554-Ag-1/ GM-Tg-cynog-SE0554-Ag-2;
GM-Tg-felg-SE0554-Ag-1/ GM-Tg-felg-SE0554-Ag-2; GM-Tg-cang-SE0554-Ag-1/ GM-Tg-cang-SE0554-Ag-2;
GM-Tg-bovg-SE0554-Ag-1/ GM-Tg-bovg-SE0554-Ag-2; GM-Tg-equg-SE0554-Ag-1/ GM-Tg-equg-SE0554-Ag-2
Products Name WFIKKN2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name WFIKKN2
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WFIKKN2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.